Internet survey on Epipen auto-injector for patients with a history of anaphylaxis

Internet survey on adrenaline auto-injector for patients with a history of anaphylaxis - Internet survey on adrenaline auto-injector

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041693

Enrollment

1000

Registered

2020-09-05

Start date

2020-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaphylaxis or Anaphylactic shock

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Large-scale panels, the panel that corresponds to any one or more of 1)allergic rhinitis 2)atopic dermatitis 3)bronchial asthma 2. Respondents who have had anaphylaxis in the past or their children

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Background factors for those with a history of anaphylaxis who do not have adrenaline auto-injector	—

Secondary

Measure	Time frame
1)Background factors by region for those with a history of anaphylaxis and who do not have adrenaline auto-injector 2)Background factors by age for those with a history of anaphylaxis and who do not have adrenaline auto-injector 3)Background factors by anaphylaxis onset and history of anaphylaxis patients who do not have adrenaline auto-injector 4)(First visit) Prescription rate of adrenaline auto-injector by department 5)(Family physician) Prescription rate of adrenaline auto-injector by department 6)Re-prescription status of adrenaline auto-injector 7)Relationship between parents and children with and without history, parents with and without history of anaphylaxis, and thought/behavioral patterns for adrenaline auto-injector	—

Measure

Time frame

1)Background factors by region for those with a history of anaphylaxis and who do not have adrenaline auto-injector 2)Background factors by age for those with a history of anaphylaxis and who do not have adrenaline auto-injector 3)Background factors by anaphylaxis onset and history of anaphylaxis patients who do not have adrenaline auto-injector 4)(First visit) Prescription rate of adrenaline auto-injector by department 5)(Family physician) Prescription rate of adrenaline auto-injector by department 6)Re-prescription status of adrenaline auto-injector 7)Relationship between parents and children with and without history, parents with and without history of anaphylaxis, and thought/behavioral patterns for adrenaline auto-injector

—

Countries

Japan

Contacts

Public ContactYoichi Nakamura

Yokohama City Minato Red Cross Hospital Medical Center for Allergic and Immune Diseases

nakamura.alle@yokohama.jrc.or.jp045-628-6381

Outcome results